The Spatial Heterogeneity in Newly Diagnosed Multiple Myeloma Patients - from Sub-Clonal Architecture to the Immune Microenvironment
Lukas John(University of Hohenheim), Niels Weinhold(German Cancer Research Center), Katharina Bauer(Heidelberg University), Stephan M. Tirier(German Cancer Research Center), Stefanie Huhn(Heidelberg University), Sabrina Schumacher(German Cancer Research Center), Carsten Müller‐Tidow(Heidelberg University), Simon Steiger(German Cancer Research Center), Alexandra M. Poos(German Cancer Research Center), Alexander Brobeil(Heidelberg University), Hartmut Goldschmidt(Heidelberg University), Jan‐Philipp Mallm(German Cancer Research Center), Karsten Rippe(German Cancer Research Center), Nina Prokoph(MRC Laboratory of Molecular Biology), Raphael Lutz(German Cancer Research Center), Christoph Rehnitz(Heidelberg University), Sandra Sauer(Heidelberg University), Anja Baumann(University of Vienna), Marc‐Steffen Raab(Heidelberg University)
Cited by 6
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493